COVID-19 should spur massive investment in science and technology, Regeneron’s Yancopoulos says: a BioCentury audio interview

In addition to preparing for future pandemics, the U.S. should increase its investments in science and technology by orders of magnitude to head off crippling onslaughts of disease, Regeneron’s George Yancopoulos told BioCentury.

In a Back to School audio interview, Yancopoulos, president and CSO of Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), called out the need to invest in infrastructure capabilities, and made the case for ramping up the innovation ecosystem. The interview was one in a series with key opinion leaders for the Back to School 2020 package (see Cover Story: “The Imperative of COVID-19”). ...